Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00403104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: ONO-2506PO
DRUG: ONO-2506PO

Sponsor

Ono Pharmaceutical Co., Ltd.